TrialNeuro-oncology2015

Phase II study of panobinostat in combination with bevacizumab for recurrent glioblastoma and anaplastic glioma.

Eudocia Q Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.